Gilead to Test Experimental Drug on Adolescent COVID-19 Patients
Gilead to Test Experimental Drug on Adolescent COVID-19 Patients

Drugmaker Gilead will be administering the experimental drug Remdesivir to pediatric patients who contracted COVID-19.

The goal is to measure the effectiveness of the drug in newborns and adolescents.